ESHAP

Etoposide, methylprednisolone, cytarabine and cisplatin (ESHAP) is one of the mostly widely used chemotherapy regimens for patients with relapsed lymphomas. Cisplatin administration is commonly associated with electrolyte imbalance. Careful monitoring of renal function and serum electrolytes is therefore essential in this setting.

Aims: To review the practice of electrolyte monitoring – potassium (K), calcium (Ca) and magnesium (Mg) – in patients receiving ESHAP and the frequency and severity of abnormalities and their management.